Movement Alert｜Edwards Lifesciences Intraday Rise 3.02% in Regular Trading, Price Target Hike Reinforces Post-Earnings Optimism

Market Focus

Nov 10

On November 10, Edwards Lifesciences recorded an Intraday Rise of 3.02% in Regular Trading, trading at $105.16 per share with turnover of $368 million.

The move coincided with a fresh analyst target increase to $115 from $101, reinforcing constructive sentiment after the company recently reported quarterly results above expectations.

Edwards Lifesciences posted adjusted EPS of $0.80 for the September quarter on revenue of $1.716 billion, ahead of consensus forecasts of $0.74 and $1.676 billion. The company also narrowed its full-year adjusted EPS guidance to $2.97 to $3.05, versus market expectations near $3. Earlier, another brokerage upgraded the stock to buy and lifted its target price to $113, while positive clinical and product milestones in structural heart devices have continued to support the broader growth narrative.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1181513913"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1181513913\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1181513913?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-11-10 03:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181513913","market":"us","top_or_hot":-1,"title":"Movement Alert｜Edwards Lifesciences Intraday Rise 3.02% in Regular Trading, Price Target Hike Reinforces Post-Earnings Optimism","media":"Market Focus","content":"<p><p>On November 10, Edwards Lifesciences recorded an Intraday Rise of 3.02% in Regular Trading, trading at $105.16 per share with turnover of $368 million.</p><p>The move coincided with a fresh analyst target increase to $115 from $101, reinforcing constructive sentiment after the company recently reported quarterly results above expectations.</p><p>Edwards Lifesciences posted adjusted EPS of $0.80 for the September quarter on revenue of $1.716 billion, ahead of consensus forecasts of $0.74 and $1.676 billion. The company also narrowed its full-year adjusted EPS guidance to $2.97 to $3.05, versus market expectations near $3. Earlier, another brokerage upgraded the stock to buy and lifted its target price to $113, while positive clinical and product milestones in structural heart devices have continued to support the broader growth narrative.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Edwards Lifesciences Intraday Rise 3.02% in Regular Trading, Price Target Hike Reinforces Post-Earnings Optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Edwards Lifesciences Intraday Rise 3.02% in Regular Trading, Price Target Hike Reinforces Post-Earnings Optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-11-10 03:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On November 10, Edwards Lifesciences recorded an Intraday Rise of 3.02% in Regular Trading, trading at $105.16 per share with turnover of $368 million.</p><p>The move coincided with a fresh analyst target increase to $115 from $101, reinforcing constructive sentiment after the company recently reported quarterly results above expectations.</p><p>Edwards Lifesciences posted adjusted EPS of $0.80 for the September quarter on revenue of $1.716 billion, ahead of consensus forecasts of $0.74 and $1.676 billion. The company also narrowed its full-year adjusted EPS guidance to $2.97 to $3.05, versus market expectations near $3. Earlier, another brokerage upgraded the stock to buy and lifted its target price to $113, while positive clinical and product milestones in structural heart devices have continued to support the broader growth narrative.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EW","symbol_name":"爱德华兹","start_time":0,"source_url":"","article_id":"1181513913","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181513913","pubTimestamp":1794254362,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On November 10, Edwards Lifesciences recorded an Intraday Rise of 3.02% in Regular Trading, trading at $105.16 per share with turnover of $368 million.The move coincided with a fresh analyst target...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EW":"爱德华兹"},"translate_title":"走势警报|Edwards Lifesciences 常规交易盘中上涨 3.02%，目标价上调强化财报后乐观情绪","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EW":1},"content_text":"On November 10, Edwards Lifesciences recorded an Intraday Rise of 3.02% in Regular Trading, trading at $105.16 per share with turnover of $368 million.The move coincided with a fresh analyst target increase to $115 from $101, reinforcing constructive sentiment after the company recently reported quarterly results above expectations.Edwards Lifesciences posted adjusted EPS of $0.80 for the September quarter on revenue of $1.716 billion, ahead of consensus forecasts of $0.74 and $1.676 billion. The company also narrowed its full-year adjusted EPS guidance to $2.97 to $3.05, versus market expectations near $3. Earlier, another brokerage upgraded the stock to buy and lifted its target price to $113, while positive clinical and product milestones in structural heart devices have continued to support the broader growth narrative.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}